UK markets closed

ArriVent BioPharma, Inc. (AVBP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
18.00+1.40 (+8.43%)
At close: 04:00PM EDT
17.63 -0.37 (-2.06%)
After hours: 07:16PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate-0.66-1.02-3.17-2.9
Low estimate-0.76-1.88-4.2-4.22
High estimate-0.54-0.57-2.39-2.08
Year ago EPSN/AN/A-32.38-3.17
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts2233
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings historyInvalid DateInvalid DateInvalid Date30/03/2024
Est. EPSN/AN/AN/A-1.1
Actual EPSN/AN/AN/A-0.7
DifferenceN/AN/AN/A0.4
Surprise %N/AN/AN/A36.40%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.66-1.02-3.17-2.9
7 days ago-0.66-1.02-3.17-2.9
30 days ago-0.66-1.02-3.17-2.9
60 days ago-0.57-0.66-3-2.36
90 days ago-0.48-0.52-2.69-2.26
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesAVBPIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year90.20%N/AN/AN/A
Next year8.50%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A